Fresenius SE & Co. KGaA

Earnings Release • Feb 22, 2007

News Details

Ad-hoc | 22 February 2007 07:28

Fresenius AG: Outstanding 2006 financial results

Fresenius AG / Quarter Results

Ad hoc announcement according to § 15 WpHG transmitted by DGAP - a company
of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

Outstanding 2006 financial results – Financial targets exceeded
15 % increase in dividend per share proposed
Positive outlook for 2007: Sales to increase by 8 to 10 %,
net income to grow by 20 to 25 %

2006 was the most successful year in the Company’s history. Group sales
increased by 37 % to € 10,777 million (2005: € 7,889 million). Organic
growth was 9 %. Acquisitions, in particular Renal Care Group and HELIOS
Kliniken, contributed 29 %. Divestitures had a -1 % effect on sales.
Currency translation effects had no impact.

Group EBIT increased by 49 % at actual rates and by 50 % in constant
currency to € 1,444 million (2005: € 969 million). The Group EBIT margin
improved to 13.4 % (2005: 12.3 %). Group net income grew by 49 % at actual
rates as well as in constant currency to € 330 million (2005: € 222
million). Net income includes a total of € 29 million for one-time
expenses, primarily for the early refinancing of debt, for the integration
of Renal Care Group, and for expenses related to the stock option
accounting change.

Earnings per ordinary share were € 2.15 (2005, adjusted for the share
split: € 1.76) and earnings per preference share were € 2.16 (2005,
adjusted for the share split: € 1.77). This is an increase of 22 % for both
share classes. The average number of shares grew to 153,006,012 in 2006
(2005: 125,641,248 shares).

The Management Board will propose to the Supervisory Board a dividend
increase to € 0.57 per ordinary share (2005, adjusted for the share split:
€ 0.49) and to € 0.58 per preference share (2005, adjusted for the share
split: € 0.50)

For 2007, Fresenius Group projects further improvements in sales and
earnings. Group sales are expected to grow by 8 to 10 % in constant
currency. Net income is expected to increase by 20 to 25 % in constant
currency.

(Financial statements according to US-GAAP)

The Management Board
Bad Homburg v.d.H., February 22, 2007

DGAP 22.02.2007

Language: English
Issuer: Fresenius AG
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H. Deutschland
Phone: +49 (0)6172 608-2485
Fax: +49 (0)6172 608-2488
E-mail: ir-fre@fresenius.de
WWW: www.fresenius.de
ISIN: DE0005785638, DE0005785604
WKN: 578563, 578560
Indices: MDAX
Listed: Amtlicher Markt in Frankfurt (General Standard), München,
Düsseldorf; Freiverkehr in Berlin-Bremen, Hamburg, Stuttgart;
Terminbörse EUREX

End of News DGAP News-Service

---